[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Urinary Tract Infection Testing Market Size, Share & Trends Analysis By Type (Urethritis, Cystitis, Pyelonephritis), By End-Use (Reference Laboratories, General Practitioners, Urologists, Urgent Care), By Region, And Segment Forecasts, 2022 - 2030

July 2022 | 113 pages | ID: UF10A91D5F20EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 3 Business Days

Urinary Tract Infection Testing Market Growth & Trends

The global urinary tract infection testing market is expected to reach USD 765.6 million by 2030, according to a new report by Grand View Research, Inc. The UTI testing market is witnessing growth due to factors such as rising disease burden, increasing geriatric population, rapid technological advancements, and high R&D investments by key players to introduce novel & innovative products, such as self-testing & rapid Point-of-Care (PoC) devices products.

Urinary tract infection is becoming a common global concern. According to research studies, UTI occurs in one in five adult women at some point in their life. In the U.S., about 25%-40% of women aged 20-40 have suffered a UTI. In the U.S., about 250,000 cases of pyelonephritis are reported every year. In women aged 18-19, its incidence is about 28/10,000, out of which 7% of cases require hospital admission. Genetic and cultural factors may influence its prevalence; for instance, in South Korea, the incidence of pyelonephritis is around 59/10,000. Its recurrence is more common than other UTIs, with the recurrence rate being 5.7% in men and 9% in women.

Patients with diabetes are at increased risk of developing urinary tract infections such as acute cystitis, and therefore, the increasing global prevalence of diabetes is likely to contribute to cystitis growth. According to an NCBI article, type 2 diabetes raises UTI risk and patients with type 2 diabetes experience frequent & severe UTIs. According to the International Diabetes Federation (IDF) data from 2021, approximately 643 million individuals will have diabetes by 2030 and 783 million by 2045. Moreover, the estimated prevalence of asymptomatic bacteriuria in diabetic females is 26%, compared to 6% in nondiabetic females. Such factors are expected to boost the prevalence of cystitis globally.

However, due to the rise in awareness about such diseases, the demand for specialist treatment has increased in recent years. According to the U.S. Department of Health and Human Services, in the U.S., the number of practicing urologists in 2020 was 4.07 per 100,000 populations. The report further stated that due to the rise in demand, a shortage of urologists was observed, which is likely to exceed nearly 3,600 physicians by 2025. This can impede market growth in the coming years. Moreover, COVID-19 has had a detrimental impact on the industry. Individuals with UTIs have experienced substantial disruptions in testing and emergency care.

Key players are introducing novel products to strengthen their portfolios. For instance, in September 2021, OpGen, Inc. announced initiating clinical trials of the Unyvero Urinary Tract Infection Panel. The panel can analyze a broad range of pathogens and antimicrobial resistance markers directly from a urine sample. Successful clinical trials and the launch of such technologically advanced & efficient products are anticipated to drive market growth over the coming years. Similarly, in July 2020, Uqora, Inc. (Pharmavite, LLC), a urinary health biotechnology company, launched a UTI diagnostic and management kit. The kit includes a rapid UTI diagnostic device, Clarify, compatible with a PoC and homecare setting.

Urinary Tract Infection Testing Market Highlights
  • Cystitis dominated the market in 2021, with an estimated market share of 41.56%. This can be attributed to the high incidence & recurrence rate of cystitis, increased number of product approvals, and the high number of diabetes patients who are more prone to cystitis
  • The general practitioner segment held a share of 12.41% in 2021. It is the primary point of contact for most patients with UTI, and in most cases, uncomplicated UTI is diagnosed and treated by a general practitioner
  • North America dominated the overall urinary tract infection market in terms of value. This can be attributed to better reimbursement facilities and a rise in the adoption of novel diagnostic products due to increased awareness
CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Market Segmentation and Scope
  1.1.1 Segment scope
  1.1.2 Regional scope
  1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
  1.3.1 Purchased database:
  1.3.2 GVR’s internal database
  1.3.3 Secondary sources
  1.3.4 Primary research
  1.3.5 Details of primary research
1.4 Information or Data Analysis
  1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
  1.6.1 Commodity Flow Analysis
    1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
  1.10.1 Objective
  1.10.2 Objective
  1.10.3 Objective
  1.10.4 Objective

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Summary

CHAPTER 3 URINARY TRACT INFECTION MARKET VARIABLES, TRENDS, AND SCOPE

3.1 Penetration and Growth Prospect Mapping
3.2 Regulatory Landscape
3.3 Industry Analysis - Porter’s
3.4 Consumer Behavior Analysis
3.5 PESTEL Analysis (Political & Legal, Economic, and Technological)
3.6 Epidemiology Analysis
3.7 Custom Analysis

CHAPTER 4 URINARY TRACT INFECTION MARKET: SEGMENT ANALYSIS, BY END-USE, 2017 - 2028 (USD MILLION) (VOLUME, UNITS)

4.1 Urinary Tract Infection Market: End-use Movement Analysis
4.2 General Practitioners
  4.2.1 General practitioners Market, 2017 - 2028 (USD Million)
  4.2.2 General practitioners Market, Instruments, 2017 - 2028 (USD Million)
  4.2.3 General practitioners Market, Instruments, 2017 - 2028, Volume (Units)
  4.2.4 General practitioners Market, Consumables, 2017 - 2028 (USD Million)
  4.2.5 General practitioners Market, Consumables, 2017-2028, Volume (Thousand Units)
4.3 Urologists
  4.3.1 Urologists Market, 2017 - 2028 (USD Million)
  4.3.2 Urologists Market, Instruments, 2017 - 2028 (USD Million)
  4.3.3 Urologists Market, Instruments, 2017 - 2028, Volume (Units)
  4.3.4 Urologists Market, Consumables, 2017 - 2028 (USD Million)
  4.3.5 Urologists Market, Consumables, 2017-2028, Volume (Thousand Units)
4.4 Urogynecologists
  4.4.1 Urogynecologists Market, 2017 - 2028 (USD Million)
  4.4.2 Urogynecologists Market, Instruments, 2017 - 2028 (USD Million)
  4.4.3 Urogynecologists Market, Instruments, 2017 - 2028, Volume (Units)
  4.4.4 Urogynecologists Market, Consumables, 2017 - 2028 (USD Million)
  4.4.5 Urogynecologists Market, Consumables, 2017-2028, Volume (Thousand Units)
4.5 Reference Laboratories
  4.5.1 Reference Laboratories Market, 2017 - 2028 (USD Million)
  4.5.2 Reference Laboratories Market, Instruments, 2017 - 2028 (USD Million)
  4.5.3 Reference Laboratories Market, Instruments, 2017 - 2028, Volume (Units)
  4.5.4 Reference Laboratories Market, Consumables, 2017 - 2028 (USD Million)
  4.5.5 Reference Laboratories Market, Consumables, 2017-2028, Volume (Thousand Units)
4.6 Accountable Care Organizations
4.7 Hospital Laboratories
  4.7.1 Hospital Laboratories Market, 2017 - 2028 (USD Million)
  4.7.2 Hospital Laboratories Market, Instruments, 2017 - 2028 (USD Million)
  4.7.3 Hospital Laboratories Market, Instruments, 2017 - 2028, Volume (Units)
  4.7.4 Hospital Laboratories Market, Consumables, 2017 - 2028 (USD Million)
  4.7.5 Hospital Laboratories Market, Consumables, 2017-2028, Volume (Thousand Units)
4.8 Urgent Care
  4.8.1 Urgent Care Market, 2017 - 2028 (USD Million)
  4.8.2 Urgent Care Market, Instruments, 2017 - 2028 (USD Million)
  4.8.3 Urgent Care Market, Instruments, 2017 - 2028, Volume (Units)
  4.8.4 Urgent Care Market, Consumables, 2017 - 2028 (USD Million)
  4.8.5 Urgent Care Market, Consumables, 2017-2028, Volume (Thousand Units)
4.9 Hospital Emergency Departments
  4.9.1 Hospital Emergency Departments Market, 2017 - 2028 (USD Million)
  4.9.2 Hospital Emergency Departments Market, Instruments, 2017 - 2028 (USD Million)
  4.9.3 Hospital Emergency Departments Market, Instruments, 2017 - 2028, Volume (Units)
  4.9.4 Hospital Emergency Departments Market, Consumables, 2017 - 2028 (USD Million)
  4.9.5 Hospital Emergency Departments Market, Consumables, 2017-2028, Volume (Thousand Units)
4.10 Others
  4.10.1 Others Market, 2017 - 2028 (USD Million)
  4.10.2 Others Market, Instruments, 2017 - 2028 (USD Million)
  4.10.3 Others Market, Instruments, 2017 - 2028, Volume (Units)
  4.10.4 Others Market, Consumables, 2017 - 2028 (USD Million)
  4.10.5 Others Market, Consumables, 2017-2028, Volume (Thousand Units)

CHAPTER 5 URINARY TRACT INFECTION MARKET: SEGMENT ANALYSIS, BY TYPE SCOPE, 2017 - 2028 (USD MILLION)

5.1 Urinary Tract Infection Market: Type Scope Movement Analysis
5.2 Urethritis
  5.2.1 Urethritis Market, 2017 - 2028 (USD Million)
5.3 Cystitis
  5.3.1 Cystitis market, 2017 - 2028 (USD Million)
5.4 Pyelonephritis
  5.4.1 Pyelonephritis Market, 2017 - 2028 (USD Million)

CHAPTER 6 URINARY TRACT INFECTION MARKET: SEGMENT ANALYSIS, BY REGION, 2017 - 2028 (USD MILLION)

6.1 Definition & Scope
6.2 Regional Market Share Analysis, 2020 & 2028
6.3 Regional Market Snapshot
6.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2020 to 2028
  6.4.1 North America
    6.4.1.1 North America market estimates and forecast, 2017 - 2028 (USD Million)
    6.4.1.2 U.S.
      6.4.1.2.1 U.S. Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.1.3 Canada
      6.4.1.3.1 Canada Urinary Tract Infection market, 2017 - 2028 (USD Million)
  6.4.2 Europe
    6.4.2.1 Europe Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.2.2 UK
      6.4.2.2.1 UK Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.2.3 Germany
      6.4.2.3.1 Germany Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.2.4 Spain
      6.4.2.4.1 Spain Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.2.5 France
      6.4.2.5.1 France Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.2.6 Italy
      6.4.2.6.1 Italy Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.2.7 Russia
      6.4.2.7.1 Russia Urinary Tract Infection market, 2017 - 2028 (USD Million)
  6.4.3 Asia Pacific
    6.4.3.1 Asia Pacific Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.3.2 Japan
      6.4.3.2.1 Japan Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.3.3 China
      6.4.3.3.1 China Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.3.4 India
      6.4.3.4.1 India Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.3.5 South Korea
      6.4.3.5.1 South Korea Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.3.6 Australia
      6.4.3.6.1 Australia Urinary Tract Infection market, 2017 - 2028 (USD Million)
  6.4.4 Latin America
    6.4.4.1 Latin America Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.4.2 Brazil
      6.4.4.2.1 Brazil Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.4.3 Mexico
      6.4.4.3.1 Mexico Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.4.4 Argentina
      6.4.4.4.1 Argentina Urinary Tract Infection market, 2017 - 2028 (USD Million)
  6.4.5 MEA
    6.4.5.1 MEA Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.5.2 South Africa
      6.4.5.2.1 South Africa Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.5.3 Saudi Arabia
      6.4.5.3.1 Saudi Arabia Urinary Tract Infection market, 2017 - 2028 (USD Million)
    6.4.5.4 UAE
      6.4.5.4.1 UAE Urinary Tract Infection market, 2017 - 2028 (USD Million)

CHAPTER 7 URINARY TRACT INFECTION MARKET: COMPETITIVE ANALYSIS

7.1 Recent Developments and Impact Analysis, by Key Market Participants
  7.1.1 New Product Launches
  7.1.2 Mergers and Acquisitions
  7.1.3 Partnerships and Strategic Collaboration
7.2 Company Categorization
  7.2.1 Innovators
  7.2.3 Market Leaders
7.3 Vendor Landscape
  7.3.1 List of key distributors and channel partners
7.4 Key Customers
7.5 Key Company Market Share Analysis, 2020
7.6 Public Companies
  7.6.1 Company market position analysis
  7.6.2 Competitive Dashboard Analysis
  7.6.3 Market Differentiators
7.7 Private Companies
  7.7.1 List of key emerging companies
  7.7.2 Regional Network Map
7.8 Company Profiles
  7.8.1 QIAGEN
    7.8.1.1 Company overview
    7.8.1.2 Financial performance
    7.8.1.3 Product benchmarking
    7.8.1.4 Strategic initiatives
  7.8.2 Accelerate Diagnostics, Inc.
    7.8.2.1 Company overview
    7.8.2.2 Financial performance
    7.8.2.3 Product benchmarking
  7.8.3 Bio-Rad Laboratories, Inc.
    7.8.3.1 Company overview
    7.8.3.2 Financial performance
    7.8.3.3 Product benchmarking
  7.8.4 F. Hoffmann-La Roche Ltd.
    7.8.4.1 Company overview
    7.8.4.2 Financial Performance
    7.8.4.3 Product Benchmarking
    7.8.4.4 Strategic initiatives
  7.8.5 Danaher Corporation
    7.8.5.1 Company overview
    7.8.5.2 Beckman Coulter
    7.8.5.3 Financial Performance
    7.8.5.4 Product benchmarking
    7.8.5.5 Strategic initiatives
  7.8.6 Siemens Healthcare GmbH
    7.8.6.1 Company overview
    7.8.6.2 Financial performance
    7.8.6.3 Product benchmarking
    7.8.6.4 Strategic initiatives
  7.8.7 Randox Laboratories Ltd.
    7.8.7.1 Company overview
    7.8.7.2 Product benchmarking
  7.8.8 Thermo Fisher Scientific, Inc.
    7.8.8.1 Company overview
    7.8.8.2 Financial performance
    7.8.8.3 Product benchmarking
    7.8.8.4 Strategic initiatives
  7.8.9 bioM?rieux SA
    7.8.9.1 Company overview
    7.8.9.2 Financial performance
    7.8.9.3 Product benchmarking
    7.8.9.4 Strategic initiatives
  7.8.10 T2 Biosystems, Inc.
    7.8.10.1 Company overview
    7.8.10.2 Financial performance
    7.8.10.3 Product benchmarking
    7.8.10.4 Strategic initiatives
LIST OF TABLES

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 North America urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 4 North America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 5 North America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 6 North America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 7 U.S. urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 8 U.S. urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 9 U.S. urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 10 U.S. urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 11 Canada urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 12 Canada urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 13 Canada urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 14 Canada urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 15 Europe urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 16 Europe urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 17 Europe urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 18 Europe urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 19 UK urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 20 UK urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 21 UK urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 22 UK urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 23 Germany urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 24 Germany urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 25 Germany urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 26 Germany urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 27 France urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 28 France urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 29 France urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 30 France urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 31 Italy urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 32 Italy urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 33 Italy urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 34 Italy urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 35 Spain urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 36 Spain urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 37 Spain urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 38 Spain urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 39 Asia Pacific urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 40 Asia Pacific urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 41 Asia Pacific urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 42 Asia Pacific urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 43 Japan urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 44 Japan urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 45 Japan urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 46 Japan urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 47 China urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 48 China urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 49 China urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 50 China urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 51 India urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 52 India urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 53 India urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 54 India urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 55 Australia urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 56 Australia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 57 Australia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 58 Australia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 59 South Korea urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 60 South Korea urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 61 South Korea urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 62 South Korea urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 63 Latin America urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 64 Latin America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 65 Latin America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 66 Latin America urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 67 Brazil urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 68 Brazil urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 69 Brazil urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 70 Brazil urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 71 Mexico urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 72 Mexico urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 73 Mexico urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 74 Mexico urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 75 Argentina urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 76 Argentina urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 77 Argentina urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 78 Argentina urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 79 MEA urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 80 MEA urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 81 MEA urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 82 MEA urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 83 South Africa urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 84 South Africa urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 85 South Africa urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 86 South Africa urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 87 Saudi Arabia urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 88 Saudi Arabia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
TABLE 89 Saudi Arabia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 90 Saudi Arabia urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
TABLE 91 UAE urinary tract infection testing market estimates and forecasts, by type, 2018 - 2030 (USD Million)
TABLE 92 UAE urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (USD) Million
TABLE 93 UAE urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Instruments, Volume, Units)
TABLE 94 UAE urinary tract infection testing market estimates and forecasts, by end-use, 2018 - 2030 (Consumables, Volume, Units)
Table 95 List of key distributors
LIST OF FIGURES

FIG. 1 Urinary tract infection market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 UTI market snapshot, 2020
FIG. 10 Penetration and growth prospect mapping
FIG. 11 Porter’s Five Forces Analysis
FIG. 12 Consumer behavior analysis
FIG. 13 Urinary tract infection market end-use scope outlook: Key takeaways
FIG. 14 Urinary tract infection market: end-use movement analysis
FIG. 15 General practitioners’ market, 2017 - 2028 (USD Million)
FIG. 16 General practitioners’ market, instruments, 2017 - 2028 (USD Million)
FIG. 17 General practitioners’ market, instruments, 2017 - 2028, Volume (Units)
FIG. 18 General practitioners’ market, consumables, 2017 - 2028 (USD Million)
FIG. 19 General practitioners’ market, consumables, 2017 - 2028, Volume (Thousand Units)
FIG. 20 Urologists market, 2017 - 2028 (USD Million)
FIG. 21 Urologists market, instruments, 2017 - 2028 (USD Million)
FIG. 22 Urologists market, instruments, 2017 - 2028, Volume (Units)
FIG. 23 Urologists market, consumables, 2017 - 2028 (USD Million)
FIG. 24 Urologists market, consumables, 2017 - 2028, Volume (Thousand Units)
FIG. 25 Urogynecologists market, 2017 - 2028 (USD Million)
FIG. 26 Urogynecologists market, instruments, 2017 - 2028 (USD Million)
FIG. 27 Urogynecologists market, instruments, 2017 - 2028, Volume (Units)
FIG. 28 Urogynecologists market, consumables, 2017 - 2028 (USD Million)
FIG. 29 Urogynecologists market, consumables, 2017 - 2028, Volume (Thousand Units)
FIG. 30 Reference laboratories market, 2017 - 2028 (USD Million)
FIG. 31 Reference laboratories market, instruments, 2017 - 2028 (USD Million)
FIG. 32 Reference laboratories market, instruments, 2017 - 2028, Volume (Units)
FIG. 33 Reference laboratories market, consumables, 2017 - 2028 (USD Million)
FIG. 34 Reference laboratories market, consumables, 2017 - 2028, Volume (Thousand Units)
FIG. 35 Hospital laboratories market, 2017 - 2028 (USD Million)
FIG. 36 Hospital laboratories market, instruments, 2017 - 2028 (USD Million)
FIG. 37 Hospital laboratories market, instruments, 2017 - 2028, Volume (Units)
FIG. 38 Hospital laboratories market, consumables, 2017 - 2028 (USD Million)
FIG. 39 Hospital laboratories market, consumables, 2017 - 2028, Volume (Thousand Units)
FIG. 40 Urgent care market, 2017 - 2028 (USD Million)
FIG. 41 Urgent care market, instruments, 2017 - 2028 (USD Million)
FIG. 42 Urgent care market, instruments, 2017 - 2028, Volume (Units)
FIG. 43 Urgent care market, consumables, 2017 - 2028 (USD Million)
FIG. 44 Urgent care market, consumables, 2017 - 2028, Volume (Thousand Units)
FIG. 45 Hospital emergency departments market, 2017 - 2028 (USD Million)
FIG. 46 Hospital emergency departments market, instruments, 2017 - 2028 (USD Million)
FIG. 47 Hospital emergency departments market, instruments, 2017 - 2028, Volume (Units)
FIG. 48 Hospital emergency departments market, consumables, 2017 - 2028 (USD Million)
FIG. 49 Hospital emergency departments market, consumables, 2017 - 2028, Volume (Thousand Units)
FIG. 50 Others market, 2017 - 2028 (USD Million)
FIG. 51 Others market, instruments, 2017 - 2028 (USD Million)
FIG. 52 Others market, instruments, 2017 - 2028, Volume (Units)
FIG. 53 Others market, consumables, 2017 - 2028 (USD Million)
FIG. 54 Others market, consumables, 2017 - 2028, Volume (Thousand Units)
FIG. 55 Urinary tract infection market type scope outlook: Key takeaways
FIG. 56 Urinary tract infection market: Type scope movement analysis
FIG. 57 Urethritis market, 2017 - 2028 (USD Million)
FIG. 58 Cystitis market, 2017 - 2028 (USD Million)
FIG. 59 Pyelonephritis market, 2017 - 2028 (USD Million)
FIG. 60 Regional outlook, 2020 & 2028
FIG. 61 Regional marketplace: Key takeaways
FIG. 62 North America
FIG. 63 North America urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 64 U.S.
FIG. 65 U.S. Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 66 Canada
FIG. 67 Canada Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 68 Europe
FIG. 69 Europe Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 70 UK
FIG. 71 UK Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 72 Germany
FIG. 73 Germany Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 74 Spain
FIG. 75 Spain Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 76 France
FIG. 77 France Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 78 Italy
FIG. 79 Italy Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 80 Russia
FIG. 81 Russia Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 82 Asia Pacific
FIG. 83 Asia Pacific Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 84 Japan
FIG. 85 Japan Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 86 China
FIG. 87 China Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 88 India
FIG. 89 India Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 90 South Korea
FIG. 91 South Korea Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 92 Australia
FIG. 93 Australia Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 94 Latin America
FIG. 95 Latin America Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 96 Brazil
FIG. 97 Brazil Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 98 Mexico
FIG. 99 Mexico Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 100 Argentina
FIG. 101 Argentina Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 102 Middle East and Africa
FIG. 103 MEA Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 104 South Africa
FIG. 105 South Africa Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 106 Saudi Arabia
FIG. 107 Saudi Arabia Urinary tract infection market, 2017 - 2028 (USD Million)
FIG. 108 UAE
FIG. 109 UAE Urinary tract infection market, 2017 - 2028 (USD Million)


More Publications